Medline - Class A (MDLN) closed at $39.47 on November 13, 2026, down 1.3% from the previous close, on volume of 7,181,369 shares (30-day average 9,348,744).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 3, 2026 | Strangle or Risk Reversal | 20-Nov-2630 P : 37.5 C | 6,740 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
Medline bed deaths rise to seven
Seeking Alpha News (Fri, 13-Nov 4:58 PM ET)
TipRanks (Fri, 13-Nov 10:50 AM ET)
TipRanks (Fri, 13-Nov 7:30 AM ET)
RBC Capital Keeps Their Buy Rating on Medline (MDLN)
TipRanks (Wed, 11-Nov 10:06 AM ET)
Globe Newswire (Wed, 11-Nov 6:03 AM ET)
Market Chameleon (Wed, 4-Nov 3:24 AM ET)
Medline Reports Third Quarter and Nine Months 2026 Results
Globe Newswire (Wed, 4-Nov 7:30 AM ET)
Globe Newswire (Wed, 4-Nov 6:18 AM ET)
Medline announces participation in the 2026 Jefferies Global Healthcare Conference
Globe Newswire (Mon, 2-Nov 4:15 PM ET)
Globe Newswire (Fri, 30-Oct 6:18 AM ET)
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Medline - Class A trades on the NASDAQ stock market under the symbol MDLN.
As of November 13, 2026, MDLN stock price declined to $39.47 with 7,181,369 million shares trading.
MDLN has a beta of 0.36, meaning it tends to be less sensitive to market movements. MDLN has a correlation of 0.01 to the broad based SPY ETF.
MDLN has a market cap of $34.68 billion. This is considered a Large Cap stock.
Last quarter Medline - Class A reported $8 billion in Revenue and $.44 earnings per share. This beat revenue expectation by $141 million and exceeded earnings estimates by $.10.
The top ETF exchange traded funds that MDLN belongs to (by Net Assets): VTI, VO, VXF, VTV, VOE.
MDLN support price is $38.78 and resistance is $41.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDLN shares will trade within this expected range on the day.